ArticleJournal of the Endocrine Society2026
A prospective cohort study of the factors associated with recurrence in young patients with thyroid cancer.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: The incidence of thyroid cancer in young people has increased over the past 40 years. While prognosis is favorable, recurrence rates may reach 20%. We previously reported the pathological characteristics of 220 young patients with thyroid cancer; here, we evaluated their long-term outcomes and recurrence risk. Objective: To identify predictors of recurrence in pediatric and adolescent thyroid cancer. Design Setting and Patients: A prospective cohort of 213 patients aged 5-19 years who underwent initial surgery at Fukushima Medical University Hospital between 2012 and 2020. Main Outcome Measures: Recurrence was defined as cytological evidence of cancer in the thyroid remnant or lymph nodes after initial surgery or the appearance of new tumor lesions on imaging of other organs after surgery. Results: Seventeen of 213 patients (8.0%) experienced recurrence during a median follow-up of 8 years. In the overall cohort, younger age was the strongest predictor of recurrence, particularly in patients younger than 15 years. Other pathological features such as lymph node metastasis and pathological intra-thyroidal dissemination (ITD) showed associations in univariate analysis but lost significance after adjustment for age. Conclusion: Unilateral lobectomy was not associated with an increased risk of recurrence. Recurrence was most frequent in patients <15 years and occurred more often in those with multifocal disease, advanced stage, N1b nodes, or ITD. These findings provide clinically relevant prognostic insights that may help refine clinical management in young patients with thyroid cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.